KL

Kumari Lipika

Active Director Director DIN 07203971
DIN 07203971 First appointment Jun 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2015
Shareholding value •••• Premium profile

About Kumari Lipika

Data last updated:

Kumari Lipika is a Director at Atrisma Pharmaceuticals Private Limited (since 2015). The company operates in Trading. Atrisma Pharmaceuticals Private Limited reported revenue of ₹30.7 Lakh (FY 2025).

DIN 07203971
Primary Designation Director
Industry Trading
First Appointment 22 Jun 2015
Oldest Company Age 11 yrs
Largest company Atrisma Pharmaceuticals Private Limited · ₹30.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Jun 20152015₹30.7 Lakh (FY 2025)Active

Board colleagues of Kumari Lipika

NameDINCompanyDesignation
Niraj Kumar06498908Atrisma Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Atrisma Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kumari Lipika

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumari Lipika

Kumari Lipika currently holds 1 directorship: Atrisma Pharmaceuticals Private Limited (Director, since 22 Jun 2015, revenue ₹30.7 Lakh (FY 2025)).

Kumari Lipika was first appointed on 22 Jun 2015 as Director at Atrisma Pharmaceuticals Private Limited.

The current boards of Kumari Lipika's companies include Niraj Kumar (Atrisma Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available